Search Results - "Baluna, Roxana"

Adhesion Molecules in Radiotherapy by Baluna, Roxana G., Eng, Tony Y., Thomas, Charles R.

“…Baluna, R. G., Eng, T. Y. and Thomas, C. R., Jr. Adhesion Molecules in Radiotherapy. Radiat. Res. 166, 819–831 (2006). Recent studies have documented changes…”
Get full text

How Intensive Should Radiotherapy for Head and Neck Cancer With Synchronous Distant Metastases Be? Review of Cases by Ampil, Federico L., MD, Kim, David D., DMD, MD, Ghali, Ghali E., DDS, MD, Baluna, Roxana G., MD, PhD

“…Purpose Given the differences in treatment objectives among oncologists and complexities of standards of therapy for advanced head and neck cancer (HNC), we…”
Get full text

Does the Negative Node Count Affect Disease-Free Survival in Early-Stage Oral Cavity Cancer? by Ampil, Federico L., MD, Caldito, Gloria, PhD, Ghali, Ghali E., DDS, MD, Baluna, Roxana G., MD, PhD

“…Purpose We performed a retrospective study to determine whether there is a relationship between disease-free survival and negative lymph node count in patients…”
Get full text

Evidence for a Structural Motif in Toxins and Interleukin-2 That May Be Responsible for Binding to Endothelial Cells and Initiating Vascular Leak Syndrome by Baluna, Roxana, Rizo, Josep, Gordon, Brian E., Ghetie, Victor, Vitetta, Ellen S.

“…The dose-limiting toxicity of interleukin-2 (IL-2) and immunotoxin (IT) therapy in humans is vascular leak syndrome (VLS). VLS has a complex etiology involving…”
Get full text

Is baseline bone imaging in high-risk breast cancer patients justified? by Ampil, Federico L, Li, Benjamin D L, Burton, Gary V, Kim, Roger H, Baluna, Roxana G, Chu, Quyen

Get more information

Post-laryngectomy stomal cancer recurrences, re-treatment decisions and outcomes: Case series by Ampil, Federico, MD, Ghali, Ghali, DDS, MD, Caldito, Gloria, PhD, Baluna, Roxana, MD, PhD

“…Summary Objective Post-laryngectomy stomal cancer recurrences pose management problems because aggressive therapeutic interventions have already often been…”
Get full text

Humeral metastasis in patients with stage IV non-small-cell lung cancer portends a short life expectancy by Ampil, Federico, Baluna, Roxana

Get more information

Is "routine" cranial irradiation in hemiplegic lung cancer patients with brain metastases justified? by Ampil, Federico L, Baluna, Roxana

Get more information

Postoperative management in laryngeal cancer with subglottic extension and histologically negative nodes: which patients need adjuvant radiotherapy? by Ampil, Federico, Nathan, Cherie-Ann O, Lian, Timothy, Baluna, Roxana, Milligan, Edward, Caldito, Gloria

“…We conducted a study of 19 patients who had laryngeal cancer with subglottic extension (LCSE) and pathologically negative lymph nodes (pN0) following total…”
Get full text

Paraplegia of spinal epidural compression by metastatic breast cancer and urgent radiotherapy—timeliness for naught? by Ampil, Federico L., Baluna, Roxana, Burton, Gary, Nanda, Anil

“…Four patients who became paraplegic because of spinal epidural compression by metastatic breast cancer were treated for palliation by external beam radiation…”
Get full text

Radiotherapy for cervical spine metastases in breast cancer patients by Ampil, Federico, Caldito, Gloria, Thibodeaux, Joel, Sangster, Guillermo, Baluna, Roxana

“…Background Although cervical spine metastasis in breast cancer patients is the least frequent of metastatic disease to the spinal column, it is nonetheless a…”
Get full text

The Effect of a Monoclonal Antibody Coupled to Ricin A Chain-Derived Peptides on Endothelial Cells in Vitro: Insights into Toxin-Mediated Vascular Damage by Baluna, Roxana, Coleman, Elaine, Jones, Chandria, Ghetie, Victor, Vitetta, Ellen S.

“…Immunotoxins (ITs) containing plant or bacterial toxins have a dose-limiting toxicity of vascular leak syndrome (VLS) in humans. The active A chain of ricin…”
Get full text

Vascular leak syndrome: a side effect of immunotherapy by Baluna, Roxana, Vitetta, Ellen S

“…The major dose-limiting toxicity of interleukin-2 (IL-2) and of immunotoxin (IT) therapies is vascular leak syndrome (VLS). VLS is characterized by an increase…”
Get full text

An in vivo model to study immunotoxin-induced vascular leak in human tissue by Baluna, R, Vitetta, E S

“…Phase I/II clinical trials using ricin A chain-containing immunotoxins (RTA-ITs) in > 125 patients with lymphoma have established that vascular leak syndrome…”
Get more information

Decreases in levels of serum fibronectin predict the severity of vascular leak syndrome in patients treated with ricin A chain-containing immunotoxins by BALUNA, R, SAUSVILLE, E. E, STONE, M. J, STETLER-STEVENSON, M. A, UHR, J. W, VITETTA, E. S

“…The major dose-limiting adverse effect of ricin A chain-containing immunotoxin (IT) therapy is vascular leak syndrome (VLS). Since plasma fibronectin (Fn)…”
Get full text

Hemagglutination assay for human serum fibronectin by Bălună, R G, Barac, D, Tarnavschi, R, Belaşcu, I

“…A hemagglutination assay for human serum fibronectin (Fn) is described. The assay is based on the capacity of Fn to bind to gelatin. Purified and human serum…”
Get more information

Fibronectin inhibits the cytotoxic effect of ricin A chain on endothelial cells by Baluna, Roxana, Ghetie, Victor, Oppenheimer-Marks, Nancy, Vitetta, Ellen S.

“…We have previously reported that after in vitro treatment with deglycosylated ricin A chain (dgRTA), human umbilical vein endothelial cells (HUVECs) undergo…”
Get full text